These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11362341)

  • 21. Agouron starts phase III protease inhibitor studies.
    AIDS Treat News; 1996 Feb; (no 240):4-5. PubMed ID: 11363185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3TC and AZT.
    Treat Rev; 1995; (no 17):2. PubMed ID: 11362294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple combination superior to double combination.
    Grodeck B
    Posit Aware; 1995; ():6. PubMed ID: 11362210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New double vs. triple antiviral combination study, CD4 200-500, no prior treatment.
    James JS
    AIDS Treat News; 1995 Dec; (no 236):7. PubMed ID: 11363052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To treat or not to treat--approaches to antiretroviral therapy. Interview by Anthony J. Japour.
    Coombs R; Cotton D; Hammer S; Saag M; van der Horst C
    AIDS Clin Care; 1996 Jan; 8(1):1-4. PubMed ID: 11363056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New protease inhibitor studies.
    Treat Rev; 1995 May; (no 18):2. PubMed ID: 11362591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eradication of HIV: the cutting edge of clinical trial design.
    Crit Path AIDS Proj; 1996; (No 31):16-7. PubMed ID: 11363825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of two studies: Delta I/II and ACTG 175].
    Biehler GV
    Sidahora; 1996 Dec-1997 Jan; ():37-40. PubMed ID: 11363441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protease inhibitors shine in triple combinations.
    AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New trials reach same conclusion: two drugs are better than AZT alone.
    AIDS Alert; 1995 Nov; 10(11):133-6. PubMed ID: 11362921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Back to the nukes.
    Smart T
    GMHC Treat Issues; 1996 Feb; 10(2):6-7. PubMed ID: 11363383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination treatment and single drugs: interview with Margaret Poscher, M.D. Interview by John S. James.
    Poscher M
    AIDS Treat News; 1995 Jul; (no 226):2-4 contd. PubMed ID: 11362613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-drug combos.
    Posit Aware; 1996; 7(1):6. PubMed ID: 11363125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3TC compassionate use protocol improved.
    Smart T; Torres G
    GMHC Treat Issues; 1995; 9(7/8):10. PubMed ID: 11362650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major study shows AZT monotherapy inferior.
    James JS
    AIDS Treat News; 1995 Sep; (no 231):3-4. PubMed ID: 11362867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral drug resistance.
    Japour AJ
    AIDS Clin Care; 1995 Aug; 7(8):63-5, 67. PubMed ID: 11362787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDA triple header. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):10-20, 22. PubMed ID: 11362792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study results at a glance.
    AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Closing the circle on HIV--or not.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Oct; 1(9):10-4, 17-29 contd. PubMed ID: 11362964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.